27354640|t|Effect of Xenotransplantation Site on MicroRNA Expression of Human Colon Cancer Stem Cells
27354640|a|Cancer stem cells (CSCs) have a high tumorigenic ability to form patient-derived tumor xenografts (PDXs). PDXs are an attractive pre-clinical model, but gene expression and biological behavior of cancer cells in the tumor will change during establishment and passage of PDXs. Human colon cancer PDX was established and passaged either subcutaneously or orthotopically into the murine intestine. Histology and flow cytometric profile of the surgical specimen and the PDX were analyzed. CSCs were then isolated from the tumors and their microRNA (miRNA) expression was analyzed by semi-quantitative polymerase chain reaction. The surgical specimens and PDXs were histologically similar. The size of CSC population increased and expression of miRNA s in CSCs changed in the passaged PDXs. Expression of oncogenic miRNAs was highly up-regulated in the CSCs of the orthotopically passaged PDXs. The xenotransplantation site and the number of tumor passages affect the miRNA expression of human colon CSCs.
27354640	0	6	Effect	T080	C1280500
27354640	10	29	Xenotransplantation	T061	C0520484
27354640	30	34	Site	T082	C0205145
27354640	38	46	MicroRNA	T114,T123	C1101610
27354640	47	57	Expression	T045	C0017262
27354640	61	66	Human	T016	C0086418
27354640	67	79	Colon Cancer	T191	C0699790
27354640	80	90	Stem Cells	T025	C0038250
27354640	91	108	Cancer stem cells	T025	C1956422
27354640	110	114	CSCs	T025	C1956422
27354640	123	127	high	T080	C0205250
27354640	128	139	tumorigenic	T191	C0007621
27354640	140	147	ability	T032	C0085732
27354640	156	188	patient-derived tumor xenografts	T050	C4050317
27354640	190	194	PDXs	T050	C4050317
27354640	197	201	PDXs	T050	C4050317
27354640	209	219	attractive	T080	C2346874
27354640	220	238	pre-clinical model	T170	C1514292
27354640	244	259	gene expression	T045	C0017262
27354640	264	283	biological behavior	T070	C0001398
27354640	287	299	cancer cells	T025	C0334227
27354640	307	312	tumor	T191	C0027651
27354640	318	324	change	T169	C0392747
27354640	332	345	establishment	T080	C0443211
27354640	361	365	PDXs	T050	C4050317
27354640	367	372	Human	T016	C0086418
27354640	373	385	colon cancer	T191	C0699790
27354640	386	389	PDX	T050	C4050317
27354640	394	405	established	T080	C0443211
27354640	410	418	passaged	T059	C1709474
27354640	426	440	subcutaneously	T082	C0443315
27354640	444	458	orthotopically	T082	C0574893
27354640	468	474	murine	T015	C0025929
27354640	475	484	intestine	T023	C0021853
27354640	486	495	Histology	T091	C0019638
27354640	500	515	flow cytometric	T059	C0016263
27354640	516	523	profile	T059	C1979963
27354640	531	539	surgical	T061	C0543467
27354640	540	548	specimen	T077	C2347026
27354640	557	560	PDX	T050	C4050317
27354640	566	574	analyzed	T062	C0936012
27354640	576	580	CSCs	T025	C1956422
27354640	591	599	isolated	T169	C0205409
27354640	609	615	tumors	T191	C0027651
27354640	626	634	microRNA	T114,T123	C1101610
27354640	636	641	miRNA	T114,T123	C1101610
27354640	643	653	expression	T045	C0017262
27354640	658	666	analyzed	T062	C0936012
27354640	670	713	semi-quantitative polymerase chain reaction	T059	C2733022
27354640	719	727	surgical	T061	C0543467
27354640	728	737	specimens	T077	C2347026
27354640	742	746	PDXs	T050	C4050317
27354640	752	766	histologically	T091	C0019638
27354640	767	774	similar	T080	C2348205
27354640	780	784	size	T082	C0456389
27354640	788	791	CSC	T025	C1956422
27354640	792	802	population	T098	C1257890
27354640	803	812	increased	T081	C0205217
27354640	817	827	expression	T045	C0017262
27354640	831	836	miRNA	T114,T123	C1101610
27354640	842	846	CSCs	T025	C1956422
27354640	847	854	changed	T169	C0392747
27354640	862	870	passaged	T059	C1709474
27354640	871	875	PDXs	T050	C4050317
27354640	877	887	Expression	T045	C0017262
27354640	891	900	oncogenic	T131	C0007090
27354640	901	907	miRNAs	T114,T123	C1101610
27354640	912	918	highly	T080	C0205250
27354640	919	931	up-regulated	T044	C0041904
27354640	939	943	CSCs	T025	C1956422
27354640	951	965	orthotopically	T082	C0574893
27354640	966	974	passaged	T059	C1709474
27354640	975	979	PDXs	T050	C4050317
27354640	985	1004	xenotransplantation	T061	C0520484
27354640	1005	1009	site	T082	C0205145
27354640	1018	1024	number	T081	C0237753
27354640	1028	1033	tumor	T191	C0027651
27354640	1034	1042	passages	T059	C1709474
27354640	1043	1049	affect	T041	C0001721
27354640	1054	1059	miRNA	T114,T123	C1101610
27354640	1060	1070	expression	T045	C0017262
27354640	1074	1079	human	T016	C0086418
27354640	1080	1085	colon	T023	C0009368
27354640	1086	1090	CSCs	T025	C1956422